Aquino D A, Chiu F C, Brosnan C F, Norton W T
Department of Neurology, Albert Einstein College of Medicine, Bronx, New York 10461.
J Neurochem. 1988 Oct;51(4):1085-96. doi: 10.1111/j.1471-4159.1988.tb03072.x.
Glial fibrillary acidic protein (GFAP) in the spinal cords of Lewis rats with acute experimental autoimmune encephalomyelitis (EAE) was quantitated by densitometry of both stained gels and immunoblots of electrophoretically separated cytoskeletal proteins. The experimental period ranged from 7 to 65 days postinoculation (dpi). Greater than 92% of the total spinal cord GFAP was recovered in the Triton-insoluble cytoskeletal pellet; less than 2% was truly soluble. GFAP increased gradually and significantly with time, reaching a level one-and-a-half to two times greater than that of controls by 35 dpi and remaining elevated at 65 dpi. In EAE animals, GFAP was 33% of the total Triton-insoluble protein (excluding histones and other small basic proteins) at 7 dpi, rising to 48% at 65 dpi. Increases in vimentin were also noted, following a time course similar to that of GFAP. An increase in immunocytochemical staining of GFAP was noticeable at 10 dpi and became marked at 14 dpi, a time before GFAP levels had increased significantly. Thus, enhanced staining at the peak of the disease cannot be explained simply by an increase in antigen protein. Other possible explanations, such as an increase in soluble GFAP content, proteolytic degradation, or modifications in the immunochemical properties of GFAP in EAE animals, were ruled out. Both the biochemical and immunocytochemical increases in GFAP persisted through 65 dpi, even though the animals recovered from clinical signs at approximately 18 dpi.
通过对电泳分离的细胞骨架蛋白染色凝胶和免疫印迹进行光密度测定,对患有急性实验性自身免疫性脑脊髓炎(EAE)的Lewis大鼠脊髓中的胶质纤维酸性蛋白(GFAP)进行定量分析。实验期为接种后7至65天(dpi)。脊髓中超过92%的总GFAP存在于Triton不溶性细胞骨架沉淀中;真正可溶的不到2%。GFAP随时间逐渐显著增加,到35 dpi时达到比对照组高1.5至2倍的水平,并在65 dpi时保持升高。在EAE动物中,7 dpi时GFAP占总Triton不溶性蛋白(不包括组蛋白和其他小碱性蛋白)的33%,65 dpi时升至48%。波形蛋白也有增加,其时间进程与GFAP相似。10 dpi时GFAP免疫细胞化学染色增加明显,14 dpi时变得显著,此时GFAP水平尚未显著升高。因此,疾病高峰期染色增强不能简单地用抗原蛋白增加来解释。其他可能的解释,如可溶性GFAP含量增加、蛋白水解降解或EAE动物中GFAP免疫化学性质的改变,均被排除。尽管动物在大约18 dpi时从临床症状中恢复,但GFAP的生化和免疫细胞化学增加一直持续到65 dpi。